Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AAVE whale moves $22.8M in tokens – Is $140 support at risk?

AAVE whale moves $22.8M in tokens – Is $140 support at risk?

AMBCryptoAMBCrypto2026/10/24 22:04
By:AMBCrypto

As Aave [AAVE] continues its sharp decline, it appears that some long-term investors are capitulating. According to Lookonchain, an institutional investor became active again after a year and moved 156,690 AAVE, worth $22.86 million, possibly to sell.

This is a significant amount of AAVE moving into exchanges and could mean two things: either an exit or a portfolio reshuffle.

If the tokens are sold, they could put significant downside pressure on AAVE, especially now that it is in a sharp decline.

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 50px; transition: min-height 0.3s ease; } } @media only screen and (min-width: 640px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 90px; } }
AD

AAVE exchange supply on the rise

In addition to the reported exchange deposits, the supply of AAVE held on exchanges has continued to rise.

A look at the Exchange Supply Ratio (ESR) shows it rose to a three-week high of 0.1615 as of writing. The rising ESR reflects that more AAVE is now being held on exchanges.

AAVE whale moves $22.8M in tokens – Is $140 support at risk? image 0 Source: CryptoQuant

Typically, this increases the amount of tokens available for selling, signaling greater potential selling pressure. With AAVE declining, this positioning suggests market uncertainty, with traders potentially preparing to sell or hedge.

Can AAVE hold $140?

Amid the broader market pullback, AAVE remains stuck in a strong downtrend. Since facing rejection at $187 nearly three weeks ago, the altcoin has mostly closed at lower lows, with occasional upticks.

The downtrend intensified two days ago after AAVE lost the $160 support level, prompting the altcoin to drop from around $150 to a low of $141.

A look at momentum indicators further supports this bearish outlook. For starters, the altcoin’s Relative Strength Index (RSI) fell below 40 as of writing, dropping to 38 and edging deeper into bearish territory as it neared oversold levels.

AAVE whale moves $22.8M in tokens – Is $140 support at risk? image 1 Source: TradingView

At 38, the RSI indicates that bearish momentum is prevailing in the market. Likewise, the MACD has been on a downward trajectory since forming a bearish crossover weeks ago.

As a result, the MACD moved into negative territory, further supporting the bearish outlook. Taken together, these two indicators suggest that downside pressure remains strong and the current trend could continue.

Therefore, if selling activity persists, the altcoin is likely to lose its $140 support and fall to $132. To invalidate this bearish setup, AAVE needs a daily close above $155.

Final summary

  • An institutional investor moved 156,690 AAVE, worth $22.86 million, and so far deposited 62,000 AAVE into exchanges. 
  • AAVE extended its bearish streak, falling to a low of $140, as bears eye a drop towards $13.

 

 

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market